NEW YORK (GenomeWeb) – Vanderbilt University Medical Center has signed an agreement to integrate FDNA's Face2Gene next-generation phenotyping application suite into its workflow for evaluating difficult-to-diagnose patients, the company announced today.
Face2Gene uses facial analysis, deep learning, and artificial intelligence to evaluate symptoms of patients with rare genetic diseases and suggest possible diagnoses based on a database of more than 10,000 rare disease syndromes.